(1)
Treatment Related Adverse Events and Monitoring of Patients Receiving Biologic or Small Molecule Therapy for Inflammatory Bowel Disease. Can IBD Today 2024, 2 (2), 19–27. https://doi.org/10.58931/cibdt.2024.2230.